BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan · Delayed Price · Currency is TWD 35.85
-0.25 (-0.69%)
Mar 3, 2026, 1:30 PM CST
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 4.46 billion as of March 3, 2026. Its market cap has increased by 9.89% in one year.
Market Cap
4.46B
Enterprise Value
3.96B
Revenue
222.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.85
Market Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 4.46B, an increase of 64.25%. That is a compound annual growth rate of 7.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 4.49B | -5.99% |
| Dec 31, 2025 | 4.78B | 14.21% |
| Dec 31, 2024 | 4.18B | -11.18% |
| Dec 29, 2023 | 4.71B | 109.50% |
| Dec 30, 2022 | 2.25B | -18.50% |
| Dec 30, 2021 | 2.76B | -22.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 5.49B |
| Locus Cell | 5.42B |
| Panion & Bf Biotech | 5.36B |
| UnicoCell Biomed | 5.22B |
| Pharmosa Biopharm | 5.17B |
| Senhwa Biosciences | 4.48B |
| Formosa Pharmaceuticals | 4.25B |
| Energenesis Biomedical CO.,LTD. | 4.23B |